MANUEL DAVID GAHETE ORTIZALEJANDRO IBÁÑEZ COSTARAUL MIGUEL LUQUE HUERTASJUSTO PASTOR CASTAÑO FUENTES2026-01-292026-01-29201610.18632/oncotarget.65652-s2.0-84981284230https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27286OncologyPresence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumorsresearch article